Health Blueprint

Back to Longevity News

News summary

Elypta Announces Urine Biomarker Study Demonstrating Improved Five-Year Cancer Risk Prediction in 5,436 Adults

Source: PR Newswire • Published: 11 Nov 2026, 07:00

Summarized by Masters of Longevity from PR Newswire.

A three-GAG urine score identified a high-risk group that captured 54% of cancers.

Elypta Announces Urine Biomarker Study Demonstrating Improved Five-Year Cancer Risk Prediction in 5,436 Adults
Key Takeaways
  • A three-GAG urine score was linked to five-year cancer risk.
  • The predefined high-risk group was found to contain 54% of cancers.
  • The retrospective result has not established clinical utility yet.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.